{"status": "ok", "totalResults": 4, "articles": [{"source": {"id": "the-verge", "name": "The Verge"}, "author": "Jay Peters, Jon Porter", "title": "More than six thousand subreddits have gone dark to protest Reddit's API changes - The Verge", "description": "Many of Reddit\u2019s most popular communities have started to set themselves private to protest Reddit\u2019s upcoming API pricing changes that are forcing beloved third-party apps to shut down.", "url": "https://www.theverge.com/2023/6/12/23755974/reddit-subreddits-going-dark-private-protest-api-changes", "urlToImage": "https://cdn.vox-cdn.com/thumbor/XK89Z8iUT2qagVhFK6REkJj4Syg=/0x0:2040x1360/1200x628/filters:focal(1020x680:1021x681)/cdn.vox-cdn.com/uploads/chorus_asset/file/23985507/acastro_STK024_03.jpg", "publishedAt": "2023-06-12T09:20:51Z", "content": "More than six thousand subreddits have gone dark to protest Reddits API changes\r\nMore than six thousand subreddits have gone dark to protest Reddits API changes\r\n / Many subreddits are going private \u2026 [+2565 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Novartis to buy Chinook for up to $3.5 bln in boost to late-stage pipeline - Reuters.com", "description": "Novartis <a href=\"https://www.reuters.com/companies/NOVN.S/\"target=\"_blank\">(NOVN.S)</a> has agreed to acquire Seattle-based biotech firm Chinook Therapeutics <a href=\"https://www.reuters.com/companies/KDNY.O/\"target=\"_blank\">(KDNY.O)</a> for up to $3.5 billi\u2026", "url": "https://www.reuters.com/markets/deals/novartis-acquire-us-based-chinook-32-bln-upfront-2023-06-12/", "urlToImage": "https://www.reuters.com/resizer/oDJZiqA9lk0IdL7_S0Gg5o-vq08=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/4FN2THFNXJMI5A46MUWLJ4LOPE.jpg", "publishedAt": "2023-06-12T06:15:00Z", "content": "June 12 (Reuters) - Novartis (NOVN.S) has agreed to acquire Seattle-based biotech firm Chinook Therapeutics (KDNY.O) for up to $3.5 billion to boost its late-stage drug development line-up with a new\u2026 [+2293 chars]"}, {"source": {"id": "reuters", "name": "Reuters"}, "author": null, "title": "Morning Bid: Markets drift ahead of central bank extravaganza - Reuters", "description": "A look at the day ahead in European and global markets from Ankur Banerjee", "url": "https://www.reuters.com/markets/europe/global-markets-view-europe-2023-06-12/", "urlToImage": "https://www.reuters.com/resizer/wJ9UqXqbce3kE4OQcUUTqH3VmoI=/1200x628/smart/filters:quality(80)/cloudfront-us-east-2.images.arcpublishing.com/reuters/6JIYUOHOMBJ7RGNOM67O47MSHU.jpg", "publishedAt": "2023-06-12T04:37:00Z", "content": "A look at the day ahead in European and global markets from Ankur Banerjee\r\nAfter surprise interest rate hikes from the Reserve Bank of Australia and Bank of Canada, investors are a bit nervy heading\u2026 [+2096 chars]"}, {"source": {"id": "financial-times", "name": "Financial Times"}, "author": "Robert Smith, Owen Walker", "title": "UBS sets 'red lines' for Credit Suisse staff after takeover completion - Financial Times", "description": "Diktat is designed to reduce the risk of the transaction, orchestrated by the Swiss government", "url": "https://www.ft.com/content/dcadb6dc-482f-4a76-9db8-9bcbb337c40f", "urlToImage": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F9e99d321-2511-4689-83dc-e1845429df44.jpg?source=next-opengraph&fit=scale-down&width=900", "publishedAt": "2023-06-11T20:00:47Z", "content": "UBS is to impose tight restrictions on Credit Suisse bankers including a ban on new clients from high-risk countries and on complex financial products as it prepares to take over its ailing rival as \u2026 [+3907 chars]"}]}